Erlotinib Terminated Phase 1 / 2 Trials for Metastatic Non-Small Cell Lung Cancer / Non-Small Cell Lung Cancer Recurrent Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs